Jul. 16 at 12:11 PM
$BSX Med tech showing life today off heels of
$ABT reporting.
$JNJ forecasting to hit
$100 bil annual revs 2026, first in history.
Frothy tech and specs showing weakness and should lead to reallocation here imo.
Analysts completed their tasks in beating down the sector with constant PT revisions all the while maintaining buy recommendations.
This is typically the recipe for real reversal and we can star in this show starting today if we want it.
$MDT $ISRG